Yishai Ofran
0000-0002-5521-1337
Rambam Health Care Campus
2 papers found
Refreshing results…
Gilteritinib with or without venetoclax for relapsed/refractory FLT3‐mutated acute myeloid leukaemia
Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE‐A study
Missing publications? Search for publications with a matching author name.